535 related articles for article (PubMed ID: 26163537)
21. Surveillance for early detection of aggressive parathyroid disease: carcinoma and atypical adenoma in familial isolated hyperparathyroidism associated with a germline HRPT2 mutation.
Kelly TG; Shattuck TM; Reyes-Mugica M; Stewart AF; Simonds WF; Udelsman R; Arnold A; Carpenter TO
J Bone Miner Res; 2006 Oct; 21(10):1666-71. PubMed ID: 16995822
[TBL] [Abstract][Full Text] [Related]
22. EZH2 and ZFX oncogenes in malignant behaviour of parathyroid neoplasms.
Sanpaolo E; Miroballo M; Corbetta S; Verdelli C; Baorda F; Balsamo T; Graziano P; Fabrizio FP; Cinque L; Scillitani A; Muscarella LA; Guarnieri V
Endocrine; 2016 Oct; 54(1):55-59. PubMed ID: 26876532
[TBL] [Abstract][Full Text] [Related]
23. Familial isolated hyperparathyroidism is rarely caused by germline mutation in HRPT2, the gene for the hyperparathyroidism-jaw tumor syndrome.
Simonds WF; Robbins CM; Agarwal SK; Hendy GN; Carpten JD; Marx SJ
J Clin Endocrinol Metab; 2004 Jan; 89(1):96-102. PubMed ID: 14715834
[TBL] [Abstract][Full Text] [Related]
24. Molecular genetics of syndromic and non-syndromic forms of parathyroid carcinoma.
Cardoso L; Stevenson M; Thakker RV
Hum Mutat; 2017 Dec; 38(12):1621-1648. PubMed ID: 28881068
[TBL] [Abstract][Full Text] [Related]
25. Familial parathyroid tumors: diagnosis and management.
Stålberg P; Carling T
World J Surg; 2009 Nov; 33(11):2234-43. PubMed ID: 19184636
[TBL] [Abstract][Full Text] [Related]
26. Upregulation of FGFR1 expression is associated with parathyroid carcinogenesis in HPT-JT syndrome due to an HRPT2 splicing mutation.
Lee JY; Kim SY; Mo EY; Kim ES; Han JH; Maeng LS; Lee AH; Eun JW; Nam SW; Moon SD
Int J Oncol; 2014 Aug; 45(2):641-50. PubMed ID: 24889687
[TBL] [Abstract][Full Text] [Related]
27. Clinical and molecular genetics of parathyroid neoplasms.
Sharretts JM; Simonds WF
Best Pract Res Clin Endocrinol Metab; 2010 Jun; 24(3):491-502. PubMed ID: 20833339
[TBL] [Abstract][Full Text] [Related]
28. Familial isolated primary hyperparathyroidism/hyperparathyroidism-jaw tumour syndrome caused by germline gross deletion or point mutations of CDC73 gene in Chinese.
Kong J; Wang O; Nie M; Shi J; Hu Y; Jiang Y; Li M; Xia W; Meng X; Xing X
Clin Endocrinol (Oxf); 2014 Aug; 81(2):222-30. PubMed ID: 24716902
[TBL] [Abstract][Full Text] [Related]
29. Genetic analyses in patients with familial isolated hyperparathyroidism and hyperparathyroidism-jaw tumour syndrome.
Mizusawa N; Uchino S; Iwata T; Tsuyuguchi M; Suzuki Y; Mizukoshi T; Yamashita Y; Sakurai A; Suzuki S; Beniko M; Tahara H; Fujisawa M; Kamata N; Fujisawa K; Yashiro T; Nagao D; Golam HM; Sano T; Noguchi S; Yoshimoto K
Clin Endocrinol (Oxf); 2006 Jul; 65(1):9-16. PubMed ID: 16817812
[TBL] [Abstract][Full Text] [Related]
30. Insights into Hyperparathyroidism-Jaw Tumour Syndrome: From Endocrine Acumen to the Spectrum of
Gheorghe AM; Sima OC; Florescu AF; Ciuche A; Nistor C; Sandru F; Carsote M
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396977
[TBL] [Abstract][Full Text] [Related]
31. Heritable forms of primary hyperparathyroidism: a current perspective.
DeLellis RA; Mangray S
Histopathology; 2018 Jan; 72(1):117-132. PubMed ID: 29239035
[TBL] [Abstract][Full Text] [Related]
32. Familial isolated hyperparathyroidism caused by single adenoma: a distinct entity different from multiple endocrine neoplasia.
Watanabe T; Tsukamoto F; Shimizu T; Sugimoto T; Taguchi T; Nishisho I; Nakazawa H; Shiba E; Shishiba Y; Takai S
Endocr J; 1998 Oct; 45(5):637-46. PubMed ID: 10395244
[TBL] [Abstract][Full Text] [Related]
33. Familial isolated hyperparathyroidism maps to the hyperparathyroidism-jaw tumor locus in 1q21-q32 in a subset of families.
Teh BT; Farnebo F; Twigg S; Höög A; Kytölä S; Korpi-Hyövälti E; Wong FK; Nordenström J; Grimelius L; Sandelin K; Robinson B; Farnebo LO; Larsson C
J Clin Endocrinol Metab; 1998 Jun; 83(6):2114-20. PubMed ID: 9626148
[TBL] [Abstract][Full Text] [Related]
34. Genetic testing in familial isolated hyperparathyroidism: unexpected results and their implications.
Warner J; Epstein M; Sweet A; Singh D; Burgess J; Stranks S; Hill P; Perry-Keene D; Learoyd D; Robinson B; Birdsey P; Mackenzie E; Teh BT; Prins JB; Cardinal J
J Med Genet; 2004 Mar; 41(3):155-60. PubMed ID: 14985373
[TBL] [Abstract][Full Text] [Related]
35. [Surgical treatment of hyperparathyroidism].
Târcoveanu E; Niculescu D; Moldovanu R; Cotea E; Vasilescu A; Dănilă N; Lăzescu D; Ferariu D; Crumpei F; Ichim M; Zbranca E
Chirurgia (Bucur); 2009; 104(5):531-44. PubMed ID: 19943551
[TBL] [Abstract][Full Text] [Related]
36. Hereditary hyperparathyroidism--a consensus report of the European Society of Endocrine Surgeons (ESES).
Iacobone M; Carnaille B; Palazzo FF; Vriens M
Langenbecks Arch Surg; 2015 Dec; 400(8):867-86. PubMed ID: 26450137
[TBL] [Abstract][Full Text] [Related]
37. Mice deleted for cell division cycle 73 gene develop parathyroid and uterine tumours: model for the hyperparathyroidism-jaw tumour syndrome.
Walls GV; Stevenson M; Lines KE; Newey PJ; Reed AAC; Bowl MR; Jeyabalan J; Harding B; Bradley KJ; Manek S; Chen J; Wang P; Williams BO; Teh BT; Thakker RV
Oncogene; 2017 Jul; 36(28):4025-4036. PubMed ID: 28288139
[TBL] [Abstract][Full Text] [Related]
38. Primary hyperparathyroidism. A surgical perspective.
Clark OH; Duh QY
Endocrinol Metab Clin North Am; 1989 Sep; 18(3):701-14. PubMed ID: 2673768
[TBL] [Abstract][Full Text] [Related]
39. MAJOR MOLECULAR GENETIC DRIVERS IN SPORADIC PRIMARY HYPERPARATHYROIDISM.
Arnold A
Trans Am Clin Climatol Assoc; 2016; 127():235-244. PubMed ID: 28066056
[TBL] [Abstract][Full Text] [Related]
40. Primary hyperparathyroidism: a current perspective.
DeLellis RA; Mazzaglia P; Mangray S
Arch Pathol Lab Med; 2008 Aug; 132(8):1251-62. PubMed ID: 18684024
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]